MOSCOW (Sputnik) – The companies of Pfizer and BioNTech will provide the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) with the information about the third dose of its coronavirus vaccine viewed as a booster of their drug.
“[We] plan to submit the data to the FDA, EMA and other regulatory authorities in the coming weeks,” the companies said in a joint statement on late Thursday.
Pfizer and BioNTech pointed out that they had received “encouraging data” on the booster trial of the third dose of their vaccine.
The World Health Organization declared the COVID-19 outbreak a pandemic on March 11, 2020. To date, more than 185.48 million people have been infected with the coronavirus worldwide, with over 4 million fatalities, according to Johns Hopkins University.
Sourse: sputniknews.com
0.00 (0%) 0 votes
MOSCOW (Sputnik) - The Coalition for the Restoration of Democracy (CORED), which unites 18 opposition parties in Guinea, said on…
The news of an interplanetary scale comes after NASA believed it had captured its first sample with Perseverance last month,…
MOSCOW (Sputnik) - The last pipe of the second string of Nord Stream 2 has been welded, and after a…
LONDON (Sputnik) – The UK government on Monday condemned the military coup against the president of Guinea, Alpha Conde, and…